Oxford Immunotec Global Priced, Nasdaq: OXFD
Sells diagnostic tests for latent tuberculosis infection (LTBI).
Industry: Health Care
First Day Return: +28.3%
OXFD
Sells diagnostic tests for latent tuberculosis infection (LTBI).
| IPO Data | |
|---|---|
| IPO Date | 11/21/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $64 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Marlborough, MA, United States |
| Founded | 2002 |
| Employees at IPO | 151 |
| Website www.oxfordimmunotec.com | |
IPO News for Oxford Immunotec Global
Oxford Immunotec Global (OXFD) Performance
